Gatifloxacin Eye Drops Suppliers & Bulk Manufacturers
Available Forms: Ophthalmic Drops
Available Strengths: 0.5%
Reference Brands: Zymaxid (US), Zymar (EU)
Category:
Antibiotics
Gatifloxacin eye drops inhibit bacterial DNA gyrase and topoisomerase IV, blocking bacterial DNA replication and cell division. They provide rapid, broad-spectrum treatment for bacterial conjunctivitis and keratitis. Benefits include effective, targeted ocular infection relief, excellent tissue penetration, and minimal systemic absorption, promoting quick recovery with low side effects.
Gatifloxacin eye drops is available in Ophthalmic Drops
and strengths such as 0.5%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Gatifloxacin eye drops is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Gatifloxacin eye drops can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Gatifloxacin eye drops are approved in the EU and US for treating bacterial conjunctivitis and keratitis. In the EU, brands like Zymar are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with generic formulations available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and safety monitoring. Due to their widespread use, strict regulations on labeling, dosing, and usage are enforced to ensure safety and effectiveness. For expert support with regulatory dossiers and registration, visit PharmaTradz. We support seamless market access adhering to European and US standards for safe, effective ocular therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing